dc.contributor.author | Brazzelli, Miriam | |
dc.contributor.author | Cruickshank, Moira | |
dc.contributor.author | Tassie, Emma | |
dc.contributor.author | McNamee, Paul | |
dc.contributor.author | Robertson, Clare | |
dc.contributor.author | Elders, Andrew | |
dc.contributor.author | Fraser, Cynthia | |
dc.contributor.author | Hernandez, Rodolfo | |
dc.contributor.author | Lawrie, David | |
dc.contributor.author | Ramsay, Craig | |
dc.date.accessioned | 2016-02-25T12:00:05Z | |
dc.date.available | 2016-02-25T12:00:05Z | |
dc.date.issued | 2015-10 | |
dc.identifier.citation | Brazzelli , M , Cruickshank , M , Tassie , E , McNamee , P , Robertson , C , Elders , A , Fraser , C , Hernandez , R , Lawrie , D & Ramsay , C 2015 , ' Collagenase clostridium histolyticum for the treatment of Dupuytren’s contracture : systematic review and economic evaluation ' , Health Technology Assessment , vol. 19 , no. 90 , pp. 1-202 . https://doi.org/10.3310/hta19900 | en |
dc.identifier.issn | 1366-5278 | |
dc.identifier.other | PURE: 56926354 | |
dc.identifier.other | PURE UUID: 1c78de80-fbd8-4c35-be37-0a2c8f3409eb | |
dc.identifier.other | PubMed: 26524616 | |
dc.identifier.other | PubMed: 26524616 | |
dc.identifier.other | Scopus: 84946742881 | |
dc.identifier.other | ORCID: /0000-0002-5182-884X/work/69663735 | |
dc.identifier.other | ORCID: /0000-0003-4043-7349/work/84131506 | |
dc.identifier.uri | http://hdl.handle.net/2164/5550 | |
dc.description | Source of funding This report was commissioned by the National Institute for Health Research (NIHR) HTA programme as project number 13/05/01. The Health Services Research Unit and Health Economics Research Unit are core-funded by the Chief Scientist Office of the Scottish Government Health and Social Care Directorates. The views and opinions expressed are those of the authors and do not necessarily reflect those of the funders. | en |
dc.format.extent | 202 | |
dc.language.iso | eng | |
dc.relation.ispartof | Health Technology Assessment | en |
dc.rights | © Queen’s Printer and Controller of HMSO 2015. This work was produced by Brazzelli et al. under the terms of a commissioning contract issued by the Secretary of State for Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK. | en |
dc.subject | R Medicine | en |
dc.subject | National Institute for Health Research (NIHR) | en |
dc.subject | 13/05/01 | en |
dc.subject.lcc | R | en |
dc.title | Collagenase clostridium histolyticum for the treatment of Dupuytren’s contracture : systematic review and economic evaluation | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Health Services Research Unit | en |
dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
dc.contributor.institution | University of Aberdeen.Aberdeen Health Psychology Group | en |
dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
dc.contributor.institution | University of Aberdeen.Health Economics Research Unit | en |
dc.contributor.institution | University of Aberdeen.Public Health, Health Services and Primary Care | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Publisher PDF | en |
dc.identifier.doi | https://doi.org/10.3310/hta19900 | |